Clonal Trajectories in Persons with Acute Myeloid Leukemia and Normal Cytogenetics Relapsing after Intensive Chemotherapy and after Allotransplants. Does Pretransplant Conditioning Contribute to Mutation Topography?

Zhou Ya-Lan; Wu Li-Xin; Gale Robert Peter; Lu Run-Qing; Li Jin-Lan; Jiang Hao; Jiang Qian; Jiang Bin; Wang Zi-Long; He Ting-Ting; Wang Yue; Zhang Xiao-Xiao; Zhang Xiaohui; Xu Lan-Ping; Liu Kai-Yan; Huang Xiao-Jun; Ruan Guorui

首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Clonal Trajectories in Persons with Acute Myeloid Leukemia and Normal Cytogenetics Relapsing after Intensive Chemotherapy and after Allotransplants. Does Pretransplant Conditioning Contribute to Mutation Topography?

【24h】

Clonal Trajectories in Persons with Acute Myeloid Leukemia and Normal Cytogenetics Relapsing after Intensive Chemotherapy and after Allotransplants. Does Pretransplant Conditioning Contribute to Mutation Topography?

机译：急性骨髓白血病人体轨迹与强化化疗和分征后的正常细胞遗传学。预防性调节是否有助于突变形貌？

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Blood: The Journal of the American Society of Hematology》 |2018年第novaelatreatmentappr期|共3页
作者
Zhou Ya-Lan; Wu Li-Xin; Gale Robert Peter; Lu Run-Qing; Li Jin-Lan; Jiang Hao; Jiang Qian; Jiang Bin; Wang Zi-Long; He Ting-Ting; Wang Yue; Zhang Xiao-Xiao; Zhang Xiaohui; Xu Lan-Ping; Liu Kai-Yan; Huang Xiao-Jun; Ruan Guorui;
展开▼
作者单位

Peking Univ Inst Hematol Peoples Hosp Beijing Key Lab Hematopoiet Stem Cell Transplanta Beijing;

Peking Univ Inst Hematol Peoples Hosp Beijing Key Lab Hematopoiet Stem Cell Transplanta Beijing;

Imperial Coll London Dept Med Div Expt Med Haematol Res Ctr London England;

Peking Univ Inst Hematol Peoples Hosp Beijing Key Lab Hematopoiet Stem Cell Transplanta Beijing;

Peking Univ Inst Hematol Peoples Hosp Beijing Key Lab Hematopoiet Stem Cell Transplanta Beijing;

Peking Univ Inst Hematol Peoples Hosp Beijing Key Lab Hematopoiet Stem Cell Transplanta Beijing;

Peking Univ Inst Hematol Peoples Hosp Beijing Key Lab Hematopoiet Stem Cell Transplanta Beijing;

Peking Univ Inst Hematol Peoples Hosp Beijing Key Lab Hematopoiet Stem Cell Transplanta Beijing;

Peking Univ Inst Hematol Peoples Hosp Beijing Key Lab Hematopoiet Stem Cell Transplanta Beijing;

Novogene Bioinformat Inst Beijing Peoples R China;

Novogene Bioinformat Inst Beijing Peoples R China;

Novogene Bioinformat Inst Beijing Peoples R China;

Peking Univ People Hosp Beijing Peoples R China;

Peking Univ Inst Hematol Peoples Hosp Beijing Key Lab Hematopoiet Stem Cell Transplanta Beijing;

Peking Univ Inst Hematol Peoples Hosp Beijing Key Lab Hematopoiet Stem Cell Transplanta Beijing;

Peking Univ Inst Hematol Peoples Hosp Beijing Key Lab Hematopoiet Stem Cell Transplanta Beijing;

Peking Univ Inst Hematol Peoples Hosp Beijing Key Lab Hematopoiet Stem Cell Transplanta Beijing;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类血液及淋巴系疾病;
关键词

相似文献

外文文献
中文文献

1. Clonal Trajectories in Persons with Acute Myeloid Leukemia and Normal Cytogenetics Relapsing after Intensive Chemotherapy and after Allotransplants. Does Pretransplant Conditioning Contribute to Mutation Topography? [J] . Zhou Ya-Lan, Wu Li-Xin, Gale Robert Peter, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：急性骨髓白血病人体轨迹与强化化疗和分征后的正常细胞遗传学。预防性调节是否有助于突变形貌？
2. Low-dose hypomethylating agent decitabine in combination with aclacinomycin and cytarabine achieves a better outcome than standard FLAG chemotherapy in refractory/relapsed acute myeloid leukemia patients with poor-risk cytogenetics and mutations [J] . Limin Li, Xiaoqian Zhang, Hongjuan Yu, OncoTargets and therapy . 2018,第2期

机译：低剂量次甲基化剂地西他滨联合阿克拉霉素和阿糖胞苷在难治性/复发性细胞遗传学和突变风险低的急性/复发性急性髓细胞白血病患者中取得比标准FLAG化疗更好的结果
3. Clonal heterogeneity in patients with cytogenetically normal acute myeloid leukemia with NPM1 mutations [J] . DvorakovaD., RacilZ., BorskyM., Leukemia and lymphoma . 2013,第5期

机译：具有NPM1突变的细胞遗传学正常急性髓性白血病患者的克隆异质性
4. Low-dose hypomethylating agent decitabine in combination with aclacinomycin and cytarabine achieves a better outcome than standard FLAG chemotherapy in refractory/relapsed acute myeloid leukemia patients with poor-risk cytogenetics and mutations [O] . Limin Li, Xiaoqian Zhang, Hongjuan Yu, 2018

机译：低剂量次甲基化剂地西他滨联合阿克拉霉素和阿糖胞苷在难治性/复发性细胞遗传学和突变风险低的急性/复发性急性髓细胞白血病患者中取得比标准FLAG化疗更好的结果
5. Low-dose hypomethylating agent decitabine in combination with aclacinomycin and cytarabine achieves a better outcome than standard FLAG chemotherapy in refractory/relapsed acute myeloid leukemia patients with poor-risk cytogenetics and mutations [O] . Limin Li, Xiaoqian Zhang, Hongjuan Yu, 2018

机译：低剂量的低甲基化剂与海红霉素和红霉素组合的二亚滨达到了难治性/复发的急性髓性白血病患者的标准标志化疗的更好的结果，患有贫困的细胞遗传学和突变

Clonal Trajectories in Persons with Acute Myeloid Leukemia and Normal Cytogenetics Relapsing after Intensive Chemotherapy and after Allotransplants. Does Pretransplant Conditioning Contribute to Mutation Topography?

著录项

引文网络

相似文献

相关主题

期刊订阅